Calliditas Therapeutics AB Gains 31.9%
Mon, Mar 13, 2023 at 07:10 PM
Calliditas Therapeutics AB (CALT:NASDAQ) jumped higher at $22.42, a gain of 31.9%. On Mon, Mar 13, 2023, CALT:NASDAQ touched a New 2-Week High of $22.42. The stock appeared on our News Catalysts scanner on Mon, Mar 13, 2023 at 02:47 PM in the 'BIOTECH' category. From Mon, Feb 27, 2023, the stock recorded 50.00% Up Days and 27.27% Green Days
About Calliditas Therapeutics AB (CALT:NASDAQ)
Calliditas Therapeutics AB is a biopharmaceutical company in Sweden. The company is engaged in the provision of pharmaceutical products for patients with niche indications.
Top 10 Gainers:
- Provention Bio, Inc. (PRVB:NASDAQ), 259.7%
- Cipher Mining Inc. (CIFR:NASDAQ), 37.88%
- Euda Health Holdings Ltd Ord Shs (EUDA:NASDAQ), 36.63%
- Calliditas Therapeutics AB (CALT:NASDAQ), 31.9%
- Reborn Coffee Inc. (REBN:NASDAQ), 30.41%
- Antelope Enterprise Holdings Limited (AEHL:NASDAQ), 29.56%
- Hycroft Mining Holding Corporation (HYMC:NASDAQ), 28.74%
- Marathon Patent Group, Inc. (MARA:NASDAQ), 25.7%
- Ault Alliance Inc Com (AULT:NYSEMKT), 24.86%
- Kinnate Biopharma Inc. (KNTE:NASDAQ), 24.86%